SER
Price
$5.36
Change
+$0.05 (+0.94%)
Updated
Jul 18 closing price
Capitalization
53.43M
TOVX
Price
$0.48
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Capitalization
4.38M
Interact to see
Advertisement

SER vs TOVX

Header iconSER vs TOVX Comparison
Open Charts SER vs TOVXBanner chart's image
Serina Therapeutics
Price$5.36
Change+$0.05 (+0.94%)
Volume$1.18K
Capitalization53.43M
Theriva Biologics
Price$0.48
Change-$0.00 (-0.00%)
Volume$109.19K
Capitalization4.38M
SER vs TOVX Comparison Chart in %
Loading...
SER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SER vs. TOVX commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SER is a Hold and TOVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (SER: $5.36 vs. TOVX: $0.48)
Brand notoriety: SER and TOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SER: 6% vs. TOVX: 13%
Market capitalization -- SER: $53.43M vs. TOVX: $4.38M
SER [@Biotechnology] is valued at $53.43M. TOVX’s [@Biotechnology] market capitalization is $4.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SER’s FA Score shows that 0 FA rating(s) are green whileTOVX’s FA Score has 1 green FA rating(s).

  • SER’s FA Score: 0 green, 5 red.
  • TOVX’s FA Score: 1 green, 4 red.
According to our system of comparison, TOVX is a better buy in the long-term than SER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SER’s TA Score shows that 4 TA indicator(s) are bullish while TOVX’s TA Score has 3 bullish TA indicator(s).

  • SER’s TA Score: 4 bullish, 6 bearish.
  • TOVX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, TOVX is a better buy in the short-term than SER.

Price Growth

SER (@Biotechnology) experienced а -9.31% price change this week, while TOVX (@Biotechnology) price change was -3.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SER($53.4M) has a higher market cap than TOVX($4.38M). SER YTD gains are higher at: 6.986 vs. TOVX (-72.400). SER has higher annual earnings (EBITDA): -488K vs. TOVX (-18.33M). TOVX has more cash in the bank: 10M vs. SER (4.27M). SER has less debt than TOVX: SER (227K) vs TOVX (2.86M). SER (0) and TOVX (0) have equivalent revenues.
SERTOVXSER / TOVX
Capitalization53.4M4.38M1,220%
EBITDA-488K-18.33M3%
Gain YTD6.986-72.400-10%
P/E Ratio1.59N/A-
Revenue00-
Total Cash4.27M10M43%
Total Debt227K2.86M8%
FUNDAMENTALS RATINGS
SER vs TOVX: Fundamental Ratings
SER
TOVX
OUTLOOK RATING
1..100
747
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6265
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TOVX's Valuation (9) in the null industry is significantly better than the same rating for SER (82). This means that TOVX’s stock grew significantly faster than SER’s over the last 12 months.

TOVX's Profit vs Risk Rating (100) in the null industry is in the same range as SER (100). This means that TOVX’s stock grew similarly to SER’s over the last 12 months.

TOVX's SMR Rating (98) in the null industry is in the same range as SER (100). This means that TOVX’s stock grew similarly to SER’s over the last 12 months.

SER's Price Growth Rating (62) in the null industry is in the same range as TOVX (65). This means that SER’s stock grew similarly to TOVX’s over the last 12 months.

SER's P/E Growth Rating (100) in the null industry is in the same range as TOVX (100). This means that SER’s stock grew similarly to TOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SERTOVX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDB69.483.79
+5.77%
Independent Bank Corp
NTRB8.110.35
+4.51%
Nutriband
DAO8.79-0.07
-0.79%
Youdao
DVA141.16-2.22
-1.55%
DaVita
ATXG0.68-0.03
-3.79%
Addentax Group Corp

SER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SER has been loosely correlated with GERN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SER jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SER
1D Price
Change %
SER100%
+0.94%
GERN - SER
65%
Loosely correlated
-2.36%
XTLB - SER
59%
Loosely correlated
+0.57%
ELVN - SER
37%
Loosely correlated
-2.91%
ENTBF - SER
35%
Loosely correlated
N/A
TOVX - SER
34%
Loosely correlated
+1.26%
More

TOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TOVX has been loosely correlated with SER. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TOVX jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOVX
1D Price
Change %
TOVX100%
+1.26%
SER - TOVX
34%
Loosely correlated
+0.94%
XTLB - TOVX
29%
Poorly correlated
+0.57%
LABFF - TOVX
27%
Poorly correlated
N/A
GENFF - TOVX
24%
Poorly correlated
N/A
DYN - TOVX
23%
Poorly correlated
-4.04%
More